Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Mini Review
  • Mini review series: Current topic in Hypertension 2024
  • Published:

Understanding preeclampsia from cutting edge knowledge–protecting maternal and fetal health

Hypertension Research volume 47, pages 3367–3371 (2024)Cite this article

Abstract

Preeclampsia (PE) is conventionally been defined clinically by new-onset or aggravating hypertension during pregnancy >20 weeks associated with proteinuria or other organ damages. PE is a major cause of maternal and fetal morbidity and mortality globally and expected to increase even more. Nevertheless, there are still much to be established regarding pathophysiology, prediction, prevention, and management of PE and thus, research concerning PE is being actively conducted. This mini-review discusses on latest knowledge on PE.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Akaishi T, Tarasawa K, Hamada H, Iwama N, Tomita H, Akaishi M, et al. Prenatal hypertension as the risk of eclampsia, HELLP syndrome, and critical obstetric hemorrhage. Hypertens Res. 2024;47:455–66.

    Article  CAS  PubMed  Google Scholar 

  2. Hosier H, Lipkind HS, Rasheed H, DeWan AT, Rogne T. Dyslipidemia and Risk of Preeclampsia: A Multiancestry Mendelian Randomization Study. Hypertension. 2023;80:1067–76.

    Article  CAS  PubMed  Google Scholar 

  3. Peng X, He D, Peng R, Feng J, Chen D, Xie H, et al. Associations between IGFBP1 gene polymorphisms and the risk of preeclampsia and fetal growth restriction. Hypertens Res. 2023; https://doi.org/10.1038/s41440-023-01309-8.

  4. Taylor BD, Ness RB, Klebanoff MA, Tang G, Roberts JM, Hougaard DM, et al. The impact of female fetal sex on preeclampsia and the maternal immune milieu. Pregnancy Hypertens. 2018;12:53–7.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Brown RE, Noah AI, Hill AV, Taylor BD. Fetal Sexual Dimorphism and Preeclampsia Among Twin Pregnancies. Hypertension. 2024;81:614–9.

    Article  CAS  PubMed  Google Scholar 

  6. Hurrell A, Webster L, Sparkes J, Battersby C, Brockbank A, Clark K, et al. Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial. Lancet. 2024;403:619–31.

    Article  CAS  PubMed  Google Scholar 

  7. Jiang S, Zhang W, Cao Q, Rahbar M, Cooke W, Ono M, et al. ExoCounter Assays Identify Women Who May Develop Early-Onset Preeclampsia From 12.5 μL First-Trimester Serum by Characterizing Placental Small Extracellular Vesicles. Hypertension. 2023;80:1439–51.

    Article  CAS  PubMed  Google Scholar 

  8. He J, Chen C, Xu L, Xiao B, Chen Z, Wen T, et al. Diffusion-Derived Vessel Density Computed From a Simplified Intravoxel Incoherent Motion Imaging Protocol in Pregnancies Complicated by Early Preeclampsia: A Novel Biomarker of Placental Dysfunction. Hypertension. 2023;80:1658–67.

    Article  CAS  PubMed  Google Scholar 

  9. Ackerman WE, Buhimschi CS, Brown TL, Zhao G, Summerfield TL, Buhimschi IA. Transcriptomics-Based Subphenotyping of the Human Placenta Enabled by Weighted Correlation Network Analysis in Early-Onset Preeclampsia With and Without Fetal Growth Restriction. Hypertension. 2023;80:1363–74.

    Article  CAS  PubMed  Google Scholar 

  10. Chen Y, Di X, Xiang G, Liu Y, Pan X, Deng W, et al. sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development. Hypertens Res. 2024;47:849–58.

    Article  CAS  PubMed  Google Scholar 

  11. Salazar MR, Espeche WG, Minetto J, Carrera PR, Cerri G, Leiva Sisnieguez CB, et al. Uncontrolled and masked uncontrolled blood pressure in treated pregnant women with chronic hypertension and risk for preeclampsia/eclampsia. Hypertens Res. 2023;46:2729–37.

    Article  PubMed  Google Scholar 

  12. Chen Y, Huang X, Wu S, Guo P, Huang J, Zhou L, et al. Machine-learning predictive model of pregnancy-induced hypertension in the first trimester. Hypertens Res. 2023;46:2135–44.

    Article  PubMed  Google Scholar 

  13. Kovacheva VP, Eberhard BW, Cohen RY, Maher M, Saxena R, Gray KJ. Preeclampsia Prediction Using Machine Learning and Polygenic Risk Scores From Clinical and Genetic Risk Factors in Early and Late Pregnancies. Hypertension. 2024;81:264–72.

    Article  CAS  PubMed  Google Scholar 

  14. Varghese B, Joy CA, Josyula JVN, Jangili S, Talukdar RK, Mutheneni SR, et al. Machine learning-based protein signatures for differentiating hypertensive disorders of pregnancy. Hypertens Res. 2023;46:2513–26.

    Article  CAS  PubMed  Google Scholar 

  15. Magee LA, Wright D, Syngelaki A, Von Dadelszen P, Akolekar R, Wright A, et al. Preeclampsia Prevention by Timed Birth at Term. Hypertension. 2023;80:969–78.

    Article  CAS  PubMed  Google Scholar 

  16. Tanaka K, Nishigori H, Watanabe Z, Tanoue K, Iwama N, Satoh M, et al. Secondhand smoke exposure is associated with the risk of hypertensive disorders of pregnancy: the Japan Environment and Children’s Study. Hypertens Res. 2023;46:834–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Alexander BT, South AM, August P, Bertagnolli M, Ferranti EP, Grobe JL, et al. Appraising the Preclinical Evidence of the Role of the Renin-Angiotensin-Aldosterone System in Antenatal Programming of Maternal and Offspring Cardiovascular Health Across the Life Course: Moving the Field Forward: A Scientific Statement From the American Heart Association. Hypertension. 2023;80:e75–89.

    Article  CAS  PubMed  Google Scholar 

  18. Dines VA, Kattah AG, Weaver AL, Vaughan LE, Chamberlain AM, Bielinski SJ, et al. Risk of Adult Hypertension in Offspring From Pregnancies Complicated by Hypertension: Population-Based Estimates. Hypertension. 2023;80:1940–8.

    Article  CAS  PubMed  Google Scholar 

  19. Paramsothy A, Hegvik T-A, Engeland A, Bjørge T, Egeland GM, Klungsøyr K. Fetal Exposure to Preeclampsia and Later Risk of Cardiometabolic Disorders: A Population-Based Cohort Study. Hypertension. 2023;80:e158–66.

    Article  CAS  PubMed  Google Scholar 

  20. Quesada O, Kulandavelu S, Vladutiu CJ, DeFranco E, Minissian MB, Makarem N, et al. Cardiac Abnormalities in Hispanic/Latina Women With Prior De Novo Hypertensive Disorders of Pregnancy. Hypertension. 2024;81:255–63.

    Article  CAS  PubMed  Google Scholar 

  21. Arafa A, Kashima R, Shimamoto K, Kawachi H, Teramoto M, Sakai Y, et al. Hypertensive disorders of pregnancy and the risk of dementia: a systematic review and meta-analysis of cohort studies. Hypertens Res. 2024;47:859–66.

    Article  PubMed  Google Scholar 

  22. Troncoso F, Sandoval H, Ibañez B, López-Espíndola D, Bustos F, Tapia JC, et al. Reduced Brain Cortex Angiogenesis in the Offspring of the Preeclampsia-Like Syndrome. Hypertension. 2023;80:2559–71.

    Article  CAS  PubMed  Google Scholar 

  23. Charakida M, Wright A, Magee LA, Syngelaki A, Von Dadelszen P, Akolekar R, et al. Pregnancy—An Ideal Period to Identify Women at Risk for Chronic Hypertension. Hypertension. 2024;81:311–8.

    Article  CAS  PubMed  Google Scholar 

  24. Colson A, Depoix CL, Lambert I, Leducq C, Bedin M, De Beukelaer M, et al. Specific HIF-2α (Hypoxia-Inducible Factor-2) Inhibitor PT2385 Mitigates Placental Dysfunction In Vitro and in a Rat Model of Preeclampsia (RUPP). Hypertension. 2023;80:1011–23.

    Article  CAS  PubMed  Google Scholar 

  25. Grimaldi B, Kohan-Ghadr H-R, Halari CD, Nandi P, Kingdom JC, Drewlo S. Rosiglitazone-Mediated Activation of PPARγ Restores HO1 Expression in the Human Preeclamptic Placenta. Hypertension. 2023;80:2386–96.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Hypertension, Tokyo Women’s Medical University, Tokyo, Japan

    Kanako Bokuda

Authors
  1. Kanako Bokuda
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Kanako Bokuda.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bokuda, K. Understanding preeclampsia from cutting edge knowledge–protecting maternal and fetal health. Hypertens Res 47, 3367–3371 (2024). https://doi.org/10.1038/s41440-024-01932-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41440-024-01932-z

Keywords

Search

Advanced search

Quick links